Literature DB >> 2564106

Side-effects of subcutaneous apomorphine in Parkinson's disease.

S Ruggieri, F Stocchi, A Carta, A Agnoli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2564106     DOI： 10.1016/s0140-6736(89)90116-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma?

Authors:  L Dépatie; S Lal
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

Review 2.  The modern management of Parkinson's disease.

Authors:  N Quinn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-02       Impact factor: 10.154

3.  Subcutaneous apomorphine infusion in Parkinson's disease: does it have a role?

Authors:  K A Muhiddin; M T Roche; V R Pearce
Journal:  Postgrad Med J       Date:  1994-05       Impact factor: 2.401

4.  Ventricular bigeminy after subcutaneous administration of apomorphine in a patient with refractory Parkinson's disease: a case report.

Authors:  Anastasia N Kaminioti; Georgios T Nikitas; Apostolos K Terlis; Athanasios G Manolis; Thomas Thomaides; Aggeliki N Panousopoulou
Journal:  J Mov Disord       Date:  2013-05-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.